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AbstrAct
Objectives Primary aim was to compare the functional 
results at 3 months and 2 years between short and 
conventional cementless stem total hip arthroplasty 
(THA). Secondary aim was to determine the feasibility of a 
double-blind implant-related trial.
Design A prospective blinded randomised controlled 
multicentre trial in patients with osteoarthritis of the 
hip. All patients, research assistants, clinical assessors, 
investigators and data analysts were blinded to the type 
of prosthesis. Population: 150 patients between 18 and 70 
years with osteoarthritis of the hip, 75 in the short stem 
and 75 in the conventional stem group. Mean age: 60 
years (SD 7). Interventions: the Collum Femoris Preserving 
short stem versus the Zweymuller Alloclassic conventional 
stem.
Main outcome measures The Dutch version of the 
Hip Disability and Osteoarthritis Outcome Score (HOOS). 
Secondary outcomes measures: Harris Hip Score, the 
Physical Component Scale of the SF12, the Timed Up 
and Go test, Pain and the EQ-5D. Feasibility outcomes: 
continued blinding, protocol adherence and follow-up 
success rate.
results No significant difference between the two groups. 
Mean HOOS total score in the short stem group increased 
32.7 points from 36.6 (95% CI 32.9 to 40.2) preoperatively 
to 69.3 (95% CI 66.4 to 72.1) at 3 months follow-up. Mean 
HOOS total score in the conventional straight stem group 
increased 36.3 points from 37.1 (95% CI 33.9 to 40.3) 
preoperatively to 73.4 (95% CI 70.3 to 76.4) at 3 months 
follow-up. 91.2% of patients remained blinded at 2 years 
follow-up. Both protocol adherence and follow-up success 
rate were 98%.
conclusions Functional result at 3 months and 2 years 
after short stem THA is not superior to conventional 
cementless THA. There were more perioperative and 
postoperative complications in the short stem group. 
Direct comparison of two hip implants in a double-blinded 
randomised controlled trial is feasible.
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Research
strengths and limitations of this study
 ► Short stem cementless total hip arthroplasty 
potentially offers bone preservation and improved 
functional outcome. However, these benefits have 
yet to be confirmed in a randomised controlled trial 
(RCT).
 ► Hip implants are rarely compared directly in double-
blinded RCTs. This study has, however, shown 
that a valid direct comparison of two hip implants 
using strict methodological safeguards is a feasible 
concept.
 ► In this multicentre RCT, all efforts were made to 
ensure methodological quality, thereby reducing the 
risk of bias.
 ► Maximally blinded (patients, clinical assessors, 
investigators and data analysts are blinded for the 
type of implant).
 ► This study provides surgical outcomes at 3 months 
and 2 years. The longevity of these implants can only 
be compared with a long-term follow-up. We will, 
therefore, continue to follow up these patients.
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IntrODuctIOn
Total hip arthroplasty (THA) is one of the most successful 
surgical procedures of the last century.1 Conventional hip 
implants have shown 10-year survival rates of more than 
90% for cementless as well as cemented stems.2 3 There is 
a recent increase of cementless hip replacements, espe-
cially in young and more active patients.4 5
Answering the demands of an increasingly young and 
active patient population, recent developments in hip 
arthroplasty are aimed towards minimising tissue damage 
and retaining bone stock without compromising implant 
stability. This resulted in the introduction of innovative 
bone-preserving and soft-tissue-preserving implants, such 
as short stem THA.6 These innovations aim to accelerate 
early postoperative rehabilitation, improve long-lasting 
functional outcome and preserve bone stock for future 
revisions.
Despite their already widespread use in clinical practise, 
the potential functional benefits of short stem THA have 
yet to be confirmed in a randomised controlled trial 
(RCT).7 Due to a lack of adequate regulation, many 
innovative hip implants have reached the market without 
sound premarketing tests and clinical comparison with 
conventional implants. Many device innovations in hip as 
well as knee arthroplasty were easily adopted by clinicians 
and are currently commonly used, without any convincing 
high-quality evidence supporting their use.8 Some of 
these new designs have lead to failure rates of 2–10 times 
the standard of national joint registries.9 The need for 
a phased evidence-based introduction of implants is now 
more clear than ever, and the spread of undocumented 
new implants should be part of orthopaedic history.10
We aimed to compare the functional result at 3 months 
and 2 years of THA using a Collum Femoris Preserving 
(CFP) stem (Waldemar Link, Hamburg, Germany) with 
THA using a conventional straight stem, the Alloclassic 
Zweymuller stem (Zimmer-Biomet, Warsaw, USA).
In the early 1980s, Pipino et al introduced the Biody-
namic stem, with the aim to reduce proximal bone loss 
and reduce stress shielding by retaining normal biome-
chanical stresses in the bone.11 12 The main innova-
tion was the preservation of the femoral neck, thereby 
preserving proximal bone stock for future revisions. 
Furthermore, preservation of the trochanteric region 
of the femur potentially enables a more gluteus-mus-
cle-sparing approach.13 Lastly, following the curvature 
of the retained native neck of femur theoretically would 
result in more physiological offset reconstruction.
The initial Biodynamic stem showed good medi-
um-term and long-term survival rates.11 12 14 The Biody-
namic was later replaced by the CFP stem.14 15 Excellent 
survival rates of the CFP stem after a mean follow-up of 
5.1 years (min 2.0; max 11.2) were reported in nine case 
series with a total number of 1001 patients.7 15–23
The Zweymuller Alloclassic stem was standard of care 
in both participating hospitals and is widely used world-
wide. This stem has shown a 10-year survival rate of 
90%–100%.24–27 To obtain entry in neutral alignment, 
this stem requires the use of a box chisel cutting a slot in 
the lateral trochanteric fossa and extensive intramedul-
lary broaching particularly of the lateral cortex. This puts 
the insertion of the gluteus medius musculature at risk. 
Damage to the insertion of the gluteus musculature could 
be a cause of postoperative pain at the greater trochanter 
and reduced abductor strength, resulting in limping and 
a positive Trendelenburg gait.28–30
Considering the performance of current conventional 
cementless stems, the use of a short stem is only justified 
if it either results in a superior short-term functional 
outcome or better survival rates compared with conven-
tional straight stem THA.
Surgical trials are historically dominated by non-ran-
domised observational studies.31 Blinding and random 
treatment allocation in non-pharmacological hip osteoar-
thritis trials was often not reported, and overall reported 
quality was low.32 33Hip implants are rarely compared 
directly in double-blinded RCTs, since implant-related 
blinded surgical trials pose specific challenges. For 
instance, more rigorous methods are required to achieve 
allocation concealment and implement blinding, thereby 
ensuring similar distributions of prognostic factors in the 
intervention and control groups and preventing a serious 
risk of bias.31Therefore, the second aim of our study was 
assessing the feasibility of a double-blinded randomised 
controlled hip implant trial. Trial feasibility will be 
assessed based on continued blinding, protocol adher-
ence and follow-up success rate at 2 years follow-up.
Aim
The purpose of this study was to compare the functional 
result of THA using the CFP stem with THA using an Allo-
classic Zweymuller stem, measured by the Dutch version 
of the Hip disability and Osteoarthritis Outcome Score 
(HOOS) at 3 months and up to 2 year follow-up.34 We 
hypothesised that short stem THA would result in a better 
functional result at 3 months and 2 years compared with 
conventional Zweymuller straight stem THA as reflected 
in higher HOOS scores.
MethODs
trial design
We conducted a prospective double-blinded randomised 
controlled multicentre trial at two centres, A and B, both 
in the Netherlands. A total of 150 patients were included 
in the period from August 2009 to October 2012. A total 
of 100 patients from centre A and 50 patients from centre 
B were included. Three orthopaedic surgeons from 
centre A and two from centre B participated in this trial. 
All procedures were performed using a direct lateral 
transgluteal approach, although the short stem group 
required less gluteal dissection to expose the femoral 
neck and entry in to the femoral canal. The protocol was 
approved by the medical ethics committee (Verenigde 
Commissies Mensgebonden Onderzoek, Nieuwegein, the 
Netherlands). This trial is conducted according to the 
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Declaration of Helsinki and is registered in the Dutch 
trial register: http://www. trialregister. nl file number: 
NTR1560. All participants provided a written informed 
consent and were assigned to an anonymous study identi-
fication number. There were no changes in the trial design 
after initiation of the trial. A more detailed version of the 
protocol was previously published: http:// bmjopen. bmj. 
com/ content/ 6/ 3/ e010472, https://www. ncbi. nlm. nih. 
gov/ pmc/ articles/ PMC4809092/.35
We used stratified block randomisation consisting of 
a random sequence of blocks of 10 consecutive surgical 
procedures each. Randomisation was performed in the 
operating theatre, after anaesthetic induction and just 
before incision, using a sequentially numbered opaque 
sealed envelope.
Our primary endpoint was physical functioning 
measured with the Dutch version of HOOS validated by 
De Groot et al at 3 months and up to 2 year follow-up.34 36 
HOOS is a patient-administered questionnaire consisting 
of five subscales; pain, other symptoms, function in daily 
living (activities of daily living), function in sport and 
recreation (Sport/Rec) and hip-related quality of life 
(QOL). A score of 100 indicates no symptoms and 0 indi-
cates extreme symptoms.
Secondary outcome measures were: physical func-
tioning measured with another Patient-Reported 
Outcome Measure (PROM): the modified Harris Hip 
Score (mHHS), physical health measured with the Phys-
ical Component Scale of the SF-12 questionnaire (PCS-
12),37–40 walking ability measured with the Timed Up and 
Go (TUG) test, pain assessed on an 11-point Numeric 
Rating Scale (NRS), abductor strength assessed through 
a Trendelenburg test and QOL assessed with the EQ-5D 
score.41–45 Comorbidity was measured by asking patients 
for their medical history at baseline (prior to surgery). 
Specifically, patients were asked if pulmonary (yes/no) or 
cardiac comorbidities (yes/no) were present. The TUG 
test measures the time it takes to get up from a chair, walk 
3 m back and forth and sit back down on the chair. During 
the Trendelenburg test, the patient is asked to slowly raise 
the contralateral foot from the ground, flexing the hip to 
approximately 30 degrees and raising the non-stance side 
of the pelvis as high a possible. Inability to maintain the 
pelvis in this position for 30 s is considered a positive Tren-
delenburg test. A trained blinded researcher performed 
all clinical tests.
All PROMs (eg, HOOS, mHHS, SF-12 and EQ-5D) were 
administered at baseline, 6 weeks, 3, 6, 12 and 24 months. 
The safety of the intervention was evaluated by recording 
the number of reinterventions, defined as any ipsilateral 
hip reoperation, and the complications.
The second aim of this study was to assess the feasi-
bility of a double-blinded randomised controlled hip 
implant trial determined by the continued blinding rate, 
protocol adherence and follow-up success rate at 2 years 
follow-up. This aim was exploratory and a clear definition 
of ‘feasible’ is difficult. We consider a more than 90% 
success rate on all three items an acceptable threshold. 
We applied several methodological safeguards to reduce 
the risk of bias, maximise protocol adherence and reduce 
the risk of withdrawals. Selection bias was prevented 
by approaching all consecutive eligible patients and by 
randomising patients shortly before surgery. Patient 
performance bias was prevented by blinding patients 
for the type of prosthesis. Detection bias was prevented 
through blinded assessment and data analysis. All clin-
ical assessors remained blinded for the type of prosthesis 
during the follow-up period, and data processing and anal-
ysis was performed by blinded researchers (VS and LVB). 
Surgeon performance bias was prevented by analysing 
the learning curve and possible pitfalls prior to initiating 
the trial and establishing minimum requirements for 
surgeons before participation.46 Based on this study, the 
minimum required number of performed procedures 
prior to participating in this study was initially determined 
at five for each surgeon. However, to ensure adequate 
proficiency, the participating surgeons performed 10 
procedures prior to participating in the trial. Attri-
tion bias was reduced by actively stimulating patients to 
complete all questionnaires during the follow-up visits 
and involving patients with the trial progress, thereby 
minimising drop-out and lost to follow-up. Furthermore, 
the data were verified for completeness and inconsisten-
cies. Publication bias was prevented by publishing the 
protocol.35 Deblinded patients, withdrawals and protocol 
deviations were included in the intention-to-treat analysis.
Sample size calculation was based on the HOOS pain 
subscale. De Groot et al found a mean HOOS pain score of 
65.4 points with an SD of 14.3 in patients 9.5 months after 
THA.34 We considered a 10% difference in outcome clin-
ically relevant, resulting in a 7-point difference. Based on 
these assumptions (SD 14.3 and a difference of 7 points), 
setting α at 0.05 and the power level at 80% a sample 
size of 67 in each group was required to detect a statis-
tically significant difference. We expected a maximum 
drop-out rate of 10%, resulting in a total of 150 patients 
(75 patients in the curved stem group and 75 patients in 
the straight stem group).
To investigate the effect of both implants, we used 
generalised estimating equations (GEEs) for longitudinal 
analysis in SPSS (IBM). This method takes into account 
the dependency of observations within a patient and the 
fact that not all patients may be assessed at each time 
point (missing data). All patients who withdrew from 
the trial after surgery and patients who underwent revi-
sion surgery were included in an intention-to-treat anal-
ysis. In the primary GEE model, the outcome variable 
studied (eg, physical function on HOOS) was analysed as 
a dependent variable, using implant allocation (1, CFP; 
0, Zweymuller) and time as key independent variables. 
The primary endpoint of the study was on the effect at 3 
months, but all time moments were analysed in the same 
GEE model.
In the secondary GEE model, the secondary outcome 
measures were analysed in a similar way. We described 
the incidence of reoperations of both groups using 
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Figure 1 Consolidated Standards Of Reporting Trials flow chart. CFP, Collum Femoris Preserving.
Table 1 Baseline characteristics of the participating patients
Group
Age (year) BMI
Gender
(n) ASA level (n)
Cardiac 
comorbidity* (n)
Pulmonal 
comorbidity (n)
Mean±SD Mean±SD M:F I:II:III Yes:no Yes:no
Short stem
(n=75)
60.3±6.8 27.2±4.2 21:54 37:37:1 8: 67 4: 71
Conventional stem 
(n=75)
60.5±7.1 26.4±4.3 22:53 26:45:4 17: 55 6: 66
*Significance at p<0.05.
ASA, American Society of Anaesthesiologists; BMI, body mass index; F, female; M, male.
descriptive statistics. For all analyses, a two-tailed value of 
p<0.05 was considered to be significant.
results
Patient characteristics
During the enrolment period, 353 patients were consid-
ered eligible for inclusion (figure 1). The first patient 
was included on 24August 2009, while the last patient was 
included on 24 October 2012.
A total of 55 patients were excluded, despite being 
eligible: a non-participating surgeon operated 21 patients 
and 34 patients refused informed consent. A total of 150 
patients were randomised, 100 in hospital A and 50 in 
hospital B.
The short stem group consisted of 75 patients: 54 women 
and 21 men. The conventional stem group consisted of 
75 patients: 53 women and 22 men. There were signifi-
cantly more patients with a cardiac comorbidity in the 
conventional stem group (p=0.04). Remaining baseline 
characteristics were similar between both groups (table 1). 
Surgical characteristics are displayed in table 2. There 
were no significant differences.
Primary outcome
No significant difference in HOOS total and subscale 
scores was found between the two groups at any follow-up 
time points (figure 2). Both groups equally improved 
in HOOS total scores as well as in the HOOS subscale 
scores 3 months after surgery. Mean HOOS total score 
in the short stem group increased 32.7 points from 36.6 
(95% CI 32.9 to 40.2) preoperatively to 69.3 (95% CI 66.4 
to 72.1) at 3 months follow-up. Mean HOOS total score 
in the conventional straight stem group increased 36.3 
points from 37.1 (95% CI 33.9 to 40.3) preoperatively to 
73.4 (95% CI 70.3 to 76.4) at 3 months follow-up. Both 
groups demonstrated a particular increase in the mean 
HOOS pain subscale of 37.7 points and 40.4 points in 
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Table 2 Surgical characteristics of the participating 
patients
Short stem
(n=75)
Mean±SD
Conventional 
stem (n=75) 
Mean±SD
Blood loss (mL) 410.3±211.7 441.0±369.8
Duration surgery (hour) 1:01±0:19 0:56±0:12
Post-op HB (mmol/L) 8.7±0.69 8.7±0.70
Type of anaesthesia (n)
General:spinal
37: 38 41: 32*
Side (n)
R:L
44: 31 55: 20
HB, haemoglobin; L, left; R, right.
*Two missing.
the short and conventional straight stem groups, respec-
tively. The short stem preoperative HOOS pain subscale 
increased from 45.7 (95% CI 41.6 to 49.8) to 83.4 (95% 
CI 80.6 to 86.3) at 3 months follow-up. The conventional 
straight stem HOOS pain subscale increased from 44.6 
(95% CI 41.1 to 48.0) to 85.0 (95% CI 81.9 to 88.1) at 3 
months follow-up.
Patients continued to improve during the first year to 
a HOOS total score of 78.7 (95% CI 75.3 to 82.2) and 
82.5 (95% CI 79.4 to 85.7) in the short and conventional 
straight stem groups, respectively, and remained stable 
during the second year.
secondary outcome
There were no significant differences between the two 
groups in the secondary outcomes. Both groups demon-
strated a similar improvement from baseline in physical 
function as measured with mHHS, PCS-12, Pain-NRS 
score, TUG, Trendelenburg test and EQ5D (table 3, 
figures 3 and 4). For the majority of these outcomes, 
the main improvements were found at 3 months and 
continued to improve at 6 months and up to 1 year 
follow-up. During the second year, the improvements 
remained stable. We found improvements on all outcome 
measures as soon as 6 weeks after surgery, except on the 
TUG test and the Trendelenburg test. At 6 weeks, patients 
showed no change on the performance of the TUG test, 
and significantly more patients showed a positive Tren-
delenburg test at 6 weeks compared with baseline, with a 
decrease at 1 and 2 years follow-up (figure 3 and table 3).
complications
The minor and major complications are displayed in 
table 4.
There was an early deep infection at 5 weeks postoper-
atively in the straight stem group requiring debridement 
antibiotics and implant retention. There was one late 
infection in the short stem group 19 months postoper-
atively, requiring a two-stage revision to a straight stem. 
There were no other major complications in the straight 
stem group. In the short stem group, however, two femoral 
fractures occurred while preparing the femur for the 
stem. In one short stem patient, a small fracture occurred 
in the calcar region, requiring metal wiring to secure the 
fracture, followed by partial weight bearing for the first 
6 weeks postoperatively. The other periprosthetic frac-
ture, a Vancouver B1-type spiral fracture in the diaphysis 
region, required metal wiring along with plating to secure 
the fracture, followed by non-weight bearing for the first 
6 weeks postoperatively. There was one early dislocation 
on the second postoperative day in the short stem group 
for which the cup was revised. There was no aseptic stem 
loosening in either group within the 2-year follow-up.
trial feasibility
At the end of the 2-year follow-up period, 91.3% (n=137) 
of the participating patients remained blinded. All 
clinical assessors and data analysts remained blinded. 
Protocol adherence was 98% (n=147). Three protocol 
deviations occurred during surgery. In two patients, the 
T.O.P. cup instrument set was unsterile and a Trilogy 
(Zimmer-Biomet, Warsaw, USA) cementless cup was 
placed instead. Both patients however received the allo-
cated stem. In one patient, a straight stem was placed 
despite the patient being allocated to a short stem. The 
surgeon assessed the patient’s bone as too osteoporotic 
for placement of as short stem.
Follow-up success rate was 98% (n=147). At 2 years 
follow-up, a total of three patients had withdrawn from 
the study: one patient in the short stem group refused to 
fill out the questionnaires and withdrew within the first 
year; one patient in the straight stem group was unable 
to attend the follow-up visits or fill out the questionnaires 
and withdrew after 1 year follow-up; a third patient in the 
straight stem group was not fully satisfied with the results 
of the operation and withdrew after 1 year follow-up.
DIscussIOn
Key findings
Both groups demonstrated significant functional 
improvement at 3 months and continued to improve 
up to 1 year follow-up compared with preoperatively. 
However, we did not find a significant difference in these 
outcomes between the two groups at any of the time 
points. Therefore, we found no evidence for superior 
patient-reported short-term functional result after short 
stem THA compared with conventional straight stem 
THA.
limitations
This study has some limitations. All efforts were made 
to conceal the randomisation sequence for the oper-
ating surgeon. However, envelope randomisation is 
more vulnerable to tampering and therefore generally 
considered to be inferior to computer or distant rando-
misation. Initial efforts to perform digital randomisation 
were, however, unsuccessful due to persistent technical 
difficulties. Despite all efforts to achieve concealment of 
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Figure 2 HOOS total and subscale scores at each time point and accompanying p values. ADL, activities of daily living; HOOS, 
Hip disability and Osteoarthritis Outcome Score.
treatment allocation, three protocol violations occurred. 
In two patients, a Trilogy (Zimmer, Warsaw, USA) cement-
less cup was placed instead of a T.O.P. cup due to sterility 
issues with the T.O.P. cup instruments. In one patient, 
an Zweymuller Alloclassic stem was placed instead of 
the allocated CFP stem. This patient had severe osteopo-
rotic bone, unsuitable for a CFP stem according to the 
surgeon. This reveals a certain preference by this surgeon 
for conventional stems in patients with osteoporotic 
bone. The results of the intention-to-treat analysis did not 
differ from the per protocol analysis.
In our study, a total number of 205 patients were 
eligible to participate in the study, 150 of which were 
randomised resulting in a recruitment success rate of 
73% (figure 1). A total of 55 patients were considered 
eligible to participate but declined participation (n=34) 
or were operated/listed for the operation by a non-partic-
ipating surgeon (n=21) (figure 1). Patient characteristics 
of non-participating eligible patients were not collected, 
which leaves a risk for selection bias. Potential selection 
bias may limit the generalisability of our study results to 
the overall primary hip osteoarthritis patient population.
Previous literature
De Groot et al assessed the HOOS scores of 68 patients 9 
months after primary THA.34 Compared with our study, 
however, they found consistently lower HOOS scores 
in all subscales irrespective of the follow-up period. 
For instance, their mean HOOS pain score at 9 months 
follow-up was 64.2, while the HOOS pain scores in our 
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Table 3 Estimated mean and 95% CI of the Short Form 12 questionnaire Physical Component Scale (SF-12 PCS) and the 
Timed Up and Go (TUG) test
Short stem 95% CI lower 95% CI upper Straight stem 95% CI lower 95% CI upper
p Value in 
change
SF-12 PCS
  Baseline 33 32 35 34 32 36
  6 weeks 36 34 38 37 35 39 0.83
  3 months 42 40 44 44 42 46 0.55
  6 months 46 44 48 46 44 48 0.52
  1 year 48 46 50 47 45 50 0.41
  2 years 49 47 51 46 44 49 0.08
EQ5-D
  Baseline 0.62 0.57 0.68 0.59 0.54 0.65
  6 weeks 0.72 0.68 0.76 0.76 0.73 0.79 0.08
  3 months 0.82 0.79 0.85 0.81 0.78 0.85 0.55
  6 months 0.86 0.83 0.89 0.85 0.82 0.89 0.61
  1 year 0.88 0.85 0.91 0.85 0.80 0.89 0.97
  2 years 0.87 0.84 0.91 0.86 0.82 0.91 0.64
TUG
  Baseline 10.83 10.03 11.64 10.39 9.73 11.05
  6 weeks 11.01 10.15 11.87 10.74 9.93 11.56 0.78
  1 year 9.14 7.71 10.58 8.46 8.02 8.91 0.79
  2 years 8.74 8.32 9.16 8.63 8.19 9.07 0.53
Figure 3 The percentage of positive Trendelenburg test at each time point and accompanying p values. 
short stem and conventional straight stem groups were 
76.9 (95% CI 73.2 to 80.7) and 79.4 (95% CI 76 to 82.8) 
already at 6 weeks and continued to improve during the 
first year (figure 2). Unfortunately, Groot et al did not 
elaborate on the surgical technique used. We therefore 
could not explain the discrepancy between our study and 
theirs. The mean age in their study was 63.1 (31–88), 
which was comparable to our study (table 1).
Other authors, however, reported HOOS scores after 
primary THA more similar to our study. A large retro-
spective series of 537 primary THAs found a HOOS score 
of 83.1 at 1 year follow-up.47 Likewise, Nilsdotter et al 
reported a HOOS pain subscale score of 82.3 at 6 months 
follow-up.48
Paulsen et al calculated the minimal postoperative 
HOOS score acceptable to patients after primary THA, 
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Figure 4 Estimated mean and SE at each time point with accompanying p values. Left-side scale: pain on a Numeric Rating 
Scale. Right-side scale: modified Harris Hip Score. mHHS, modified Harris Hip Score; NRS, Numeric Rating Scale.
Table 4 Summary of minor and major complications in each group
Short stem Straight stem Action
Minor complications
  Urinary tract infection 0 1 Antibiotics
  Superficial infection 1 2 Antibiotics
  Deep venous thrombosis 1 0 Therapeutic dose low-molecular-weight heparin
Major complications
  Early deep infection 0 1 Debridement antibiotics and implant retention (DAIR)
  Late deep infection 1 0 Two-stage stem revision
  Dislocation 1 0 Cup revision
  Periprosthetic fracture 2 0 1. Plate fixation and stem retention
2. Metal wiring and stem retention
also known as the patient-acceptable symptom state 
(PASS) in a large series of 1239 patients.49 The PASS was 
calculated by determining the HOOS subscale cut-points 
in patients who answered ‘Excellent’, ‘Very good’ or 
‘Good’ to the question: ‘How would you describe the 
results of your operation’. The PASS cut-off point was 91 
(95% CI 91 to 92) for HOOS pain and 83 (95% CI 82 to 
84) for HOOS QOL. These cut-off points are even higher 
than our HOOS scores and those described in the litera-
ture.34 47 48 50
Berliner et al calculated the preoperative threshold 
values of HOOS.47 Patients with preoperative HOOS 
values below 32.5 or above 51 were less likely to expe-
rience a minimal clinical important difference of 9.1 
points. Our preoperative HOOS total score was 36.5 
(95% CI 32.9 to 40.2) in the short stem group and 37.1 
(95% CI 33.9 to 40.3) in the conventional straight stem 
group. These scores are in the lower spectrum of the 
preoperative HOOS value range defined by Berliner et al, 
which could result in lower overall postoperative scores in 
our study.47 This may explain the difference between the 
high PASS cut-off scores defined by Paulsen et al and the 
functional scores found in our study.49 Our mean preop-
erative total HOOS scores and accompanying 95% CIs 
were, however, comparable and within that range in both 
groups, thereby suggesting a similar responsiveness to the 
surgical procedure.47
In a 13-year follow-up study of THA using Zweymuller 
stems in 100 patients younger than 50 years, Schmolders 
et al demonstrated that despite an excellent 10-year 
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survival rate of 96.8%, radiolucent lines on radiographs 
affected the HOOS scores.50 The median HOOS score 
in patients with radiolucent lines was 74 and 89 points 
in patients without radiolucent lines. A longer follow-up 
may reveal whether reduced stress shielding in short 
stems reduces radiolucent lines with higher functional 
scores.
We previously summarised the reported survival rates 
of short stem THA, including the CFP, in the period 
1989 until 2013.7 We identified nine case series with a 
mean follow-up of 5.1 (3.0–11) years and a total of 1001 
included patients.15–23 These studies demonstrated a 
mean revision per 100 observed component years rate 
of 0.21. All studies reported a revision per 100 observed 
component years of less than 1, which corresponds to 
a projected revision rate of less than 10% at 10 years 
follow-up. However, due to the lack of well-constructed 
long-term studies, these projected revision rates remain 
estimations based on linear assumptions. We will there-
fore continue to follow up the patients in our study to 
report the survival at 5 years follow-up.
Apart from possible bone-preserving features, femoral 
neck-preserving stems may facilitate soft-tissue-pre-
serving surgery as well. A conventional lateral trans-
gluteal approach was used in both groups, to prevent 
performance bias due to the confounding effect of 
variations of the surgical approach. Femoral neck 
preserving and short curved stems, however, do not 
require complete exposure of the fossa piriformis for its 
insertion contrary to conventional cementless straight 
stems. This enables preservation of the integrity of part 
of the gluteus insertion, despite using a lateral trans-
gluteal approach.13 51 Moreover, short curved stems may 
provide easier insertion during an Anterior Minimally 
Invasive Supine approach. Nonetheless, successful 
survival rates and functional outcomes of minimally 
invasive hip approaches have been reported using both 
conventional and short stems.52
Directly comparing the outcome of two hip implants 
inherently limits the generalisability of the results to 
other cementless hip stems. The cementless stem design 
spectrum ranges from relatively bulky in the trochan-
teric region, such as the Alloclassic Zweymuller, to more 
curved trochanteric sparing designs, such as the Corail 
(DePuy Synthes, West Chester, USA), the Taperloc 
(Zimmer-Biomet, Warsaw, USA) or the Accolade (Stryker, 
Kalamazoo, USA). Potential functional benefits of short 
stems will more likely become apparent when compared 
with bulky trochanter-filling stems, such as the Alloclassic 
Zweymuller, as apposed to trochanter-sparing stems. We 
may therefore cautiously assume that the absence of func-
tional benefits of femoral neck preservation in our study 
is generalisable to other cementless stems.
There was a small incidence of complications, partic-
ularly of revisions, in both groups. However, there were 
more perioperative and postoperative major complica-
tions in the short stem group, including two perioper-
ative fractures. Since the first fracture occurred in the 
beginning of the trial and the second fracture in the 
second half of the trial, an association with a learning 
curve is not evident. However, it is likely that the risk of 
periprosthetic fractures is lower with years of experience 
with a certain stem.
A type I error is the risk of detecting an effect that is 
not present. In our study, we did not find a significant 
functional difference. A type II error, on the other hand, 
is the risk of failing to detect an effect that is present. 
This could be due to an insufficient sample size, partic-
ularly if the expected outcome is rare. Complications 
in total hip replacement are relatively rare. This study 
was sufficiently powered to provide information on the 
functional outcome of these implants. Drawing conclu-
sions on their safety, however, has a risk of a type II 
error. Larger sample sizes are needed to detect these 
potential differences in complication risk. RCTs are 
logistically challenging, which limits their sample size. 
The aggregated results of future similar trials and long-
term large-scale data from national joint registries may 
provide sufficient numbers to detect potential differ-
ences in complications.
Protecting against sources of bias
There remains a lack of well-constructed surgical 
randomised clinical trials in today’s literature. A system-
atic review by Adie et al of 150 surgical RCTs demonstrated 
poor reporting of most of the Consolidated Standards Of 
Reporting Trials items with a mean score of 12.2 out of 
22 items.53 Merely 12% of the RCTs were blinded. Chess 
and Gagnier showed that orthopaedic RCTs are no excep-
tion.54 After assessment of the reported methodological 
quality of RCTs in the top orthopaedic journals, they 
concluded that many of these studies likely have biased 
estimates of treatment effects.
Despite the widespread use of hip replacements, 
well-constructed comparative clinical trials assessing the 
clinical effectiveness of different types of THA implants are 
sparse. A comprehensive systematic review of published 
THR RCTs from 2008 by Tsertsvadze et al demonstrated a 
high risk of bias and poor reporting.55 None of the THR 
trials included or reported the experience levels and skills 
of caregivers, and most of the trials did not report the 
blinding status of patients, study personnel and outcome 
assessors. This study is therefore unique in a sense that it 
aimed to provide a valid unbiased clinical comparison of 
two hip prosthetic implants. Strenuous efforts have been 
made to reduce bias in this RCT.
conclusion
In this blinded RCT, we found no evidence for a better 
patient-reported functional result and less pain at 3 
months and 2 years after short stem compared with 
conventional straight stem cementless THA. Physical 
functioning, physcial health, walking ability, abductor 
strength and QOL were not superior in the short stem 
group. We did encounter more perioperative and post-
operative complications in the short stem group. Direct 
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comparison of two hip implants in a double-blinded 
RCT is a feasible concept if strict deblinding preventive 
measures are applied to all study organisational levels.
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